Supernus Pharmaceuticals | SUPN - Market Capitalization



Supernus Pharmaceuticals reported $2.49B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
Abbott USD 236.64B 6.58B Jun/2025
ANI Pharmaceuticals USD 1.41B 31M Jun/2025
Aurora Cannabis CAD 405.84M 81.86M Sep/2025
Bristol-Myers Squibb USD 94.2B 29.9B Jun/2025
Canopy Growth CAD 225.05M 88.93M Sep/2025
Corcept Therapeutics USD 7.78B 4.27B Jun/2025
Eli Lilly USD 738.79B 2.87B Jun/2025
Novo Nordisk A/S 1.96T 370.19B Jun/2025
Pacira USD 1.11B 43M Jun/2025
Perrigo USD 3.65B 177M Jun/2025
Pfizer USD 137.53B 6.19B Jun/2025
Supernus Pharmaceuticals USD 1.76B 65M Jun/2025
United Therapeutics USD 12.96B 934M Jun/2025
Xeris Pharmaceuticals USD 1.1B 347M Sep/2025